Fig 1.
Steps in the disease risk analysis process, reproduced from the DRA manual published by OIE and IUCN (2014).
Fig 2.
Origin of contributors to the hazard identification and assessment of sea turtle diseases.
(The world map is an Image by Clker-Free-Vector-Images from Pixabay).
Fig 3.
The PRISMA flowchart displaying the selection procedure for writing the literate-based “hazard identification” (section 3.1), “sea turtle and One Health consideration in the literature” (section 3.3.1) and “S4-S8 Appendices in S1 File”.
Table 1.
Example of an infectious bacterial health hazard summary for “Lactococcus garviae”.
Table 2.
Example of a non-infectious health hazard summary in the group of physical problems/injuries.
Table 3.
The three highest ranked hazards of each infectious and non-infectious groups as determined by panels of experts in two international workshops.
A) Turtle Health & Rehabilitation Workshop, September 2017, Townsville, Australia, B) Medicine workshop at the International Sea Turtle Symposium 2018, Kobe, Japan.
Fig 4.
The schematic interactions between sea turtles, humans, co-habiting animals and the environment (the vectors, characters and icons in this figure were downloaded from the public domain https://pixabay.com/ and were modified according to its licence).
Table 4.
One Health consideration in disease risk analysis workshop.
A) Transmission of pathogens between sea turtles in the wild and in captivity. B) Non-infectious disease transmission between human and sea turtle. C) Cultural values of sea turtles and socioeconomic aspects of sea turtle conservation.
Table 5.
Current risk management for sea turtle disease hazards with notes on difficulties and defects.
A) Infectious diseases. B) Non-infectious diseases. C) One Health.
Table 6.
Risk management options and scoring the effectiveness and feasibility in the Townsville management workshop.
A) Risk management options for Macroplastic pollution (effectiveness and feasibility reported from “1” the lowest to “10” the highest). B) Risk management options for Enterobacteriaceae and multi-resistant bacteria (effectiveness and feasibility reported from “1” the lowest to “10” the highest).
Fig 5.
The clutch translocation scenario, pathogen transmission pathways, lethal effects of predators and critical control points (the vectors, characters and icons in this figure were downloaded from the public domain https://pixabay.com/ and were modified according to its licence).